We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Shenandoah CTGrade GMP rh IGF-1 is a recombinant human protein produced from E. coli and is designed to support preclinical and clinical research, as well as commercial applications.
Size: 50 µg, 100 µg, and 1 mg. Custom sizes and packaging available on request.
Insulin-like Growth Factor 1 (IGF-1), also known as somatomedin C, is the principal effector of growth hormone and is structurally and functionally related to insulin, but with significantly stronger growth-promoting activity.
The biological activity of CTGrade GMP interleukins and growth factors is standardized, where applicable, to WHO International standards, providing cell and gene therapy developers consistent, lot-to-lot biological activity and performance.
CTGrade GMP products are manufactured in a facility that does not use or process beta- lactam containing materials. No animal- or human-derived materials were used during manufacturing or as ingredients. These products are manufactured, tested, and released in an ISO 9001:2015 certified facility following GMP. USP chapter <1043> for ancillary materials has been considered in the manufacture of these products.


Figure 1. CTGrade GMP rh IGF-1 (1 μg) was resolved with SDS-PAGE under non-reducing (NR) and reducing (R) conditions and visualized by Instant Blue staining showing a single prominent band at 7.7 kDa.


Figure 2. The biological activity of CTGrade GMP rh IGF-1 was determined in a cell proliferation assay using MCF-7 cells.


Figure 3. CTGrade GMP rh IGF-1 induces proliferation in MCF-7 cells that is consistent between lots.


Figure 4. Bioactivity comparison between CTGrade GMP rh IGF-1 and commercially-available rh IGF-1.
| Formulation | CTGrade GMP rh IGF-1 is lyophilized from a 0.2 μm filtered solution containing 0.1% Trifluoroacetic Acid (TFA) |
| Protein Purity | ≥ 98% determined by reducing and non-reducing SDS-PAGE analysis |
| Endotoxin | < 0.01 EU/μg using USP <85> / EP 2.6.14 |
| Bioactivity | ED50 is determined by the dose-dependent MCF-7 cell line cells. ED50 is typically less than 1.5 ng/mL. |
| Quality | Carrier-free and no animal- or human-derived materials were used during manufacturing |